Company not putting out FLUFF PR makes me feel very good about them. They know they don't need RMAT or FDA to make money. They can administer Myocell over seas where FDA has no jurisdiction. Sad part is the USA will once again be behind in technology.Folks this company has NO TOXIC DEBT and generating millions of dollars in revenues on their clinics. As they expand the footprint what do you think is going to happen to the share price. Don't let professional crooks scare you and steal your shares. Nothing has changed with company fundamentals and vision. They are moving ahead with or without you on board. I'm still 100% in!
Market Data 
Markets 
AI
